Search

Your search keyword '"Haiman, C.A."' showing total 234 results

Search Constraints

Start Over You searched for: Author "Haiman, C.A." Remove constraint Author: "Haiman, C.A."
234 results on '"Haiman, C.A."'

Search Results

1. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.

2. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in similar to 200,000 patients (vol 24, 69, 2022)

3. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

5. An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

6. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

7. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

8. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

9. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

10. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

11. Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium.

12. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0).

13. Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer.

14. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

15. KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness.

16. Genetic insights into biological mechanisms governing human ovarian ageing.

17. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

18. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.

19. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

20. Combined Associations of a Polygenic Risk Score and Classical Risk Factors with Breast Cancer Risk.

21. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

22. The CHEK2 variant C.349A>G is associated with prostate cancer risk and carriers share a common ancestor.

23. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

24. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

25. Associations between genetically predicted blood protein biomarkers and pancreatic cancer risk.

26. Gene-environment interactions relevant to estrogen and risk of breast cancer: Can gene-environment interactions be detected only among candidate snps from genome-wide association studies?.

27. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

28. Germline Sequencing DNA Repair Genes in 5545 Men with Aggressive and Nonaggressive Prostate Cancer.

29. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

30. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

31. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

32. The CHEK2 variant C.349A>G is associated with prostate cancer risk and carriers share a common ancestor

33. Two truncating variants in FANCC and breast cancer risk.

34. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.

35. Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts.

36. Germline sequencing DNA repair genes in 5,545 men with aggressive and non-aggressive prostate cancer.

37. Prediction and clinical utility of a contralateral breast cancer risk model.

38. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

39. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

40. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

41. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

42. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

43. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

44. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

45. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

46. Replication of genetic loci for ages at menarche and menopause in the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) study

47. Two truncating variants in FANCC and breast cancer risk

48. Genome-wide association study of germline variants and breast cancer-specific mortality

49. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

50. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

Catalog

Books, media, physical & digital resources